Journals / Türkiye Acil Tıp Dergisi / 2013 / Cilt: 13 - Sayı: 3

Can high bnp levels predict the necessity of emergency hemodialysis in patients with acute renal failure?

Böbrek yetersizliği hastalarında yüksek bnp düzeyleri acil hemodiyaliz ihtiyacını öngörebilir mi?

Pages
114–118
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We found that the mean value of BNP for 102 patients without a history of heart failure who had hemodialysis was 570.5±594.5 pg/ml and did not have hemodialysis was found 280.8±471.4 pg/ml (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives There is no known biomarker to indicate the necessity of hemodialysis in patients with acute renal failure.
📊
Key Findings & Data:We aimed to determine if plasma brain natriuretic peptide levels are useful to indicate the necessity of hemodi- alysis in patients who are diagnosed with acute renal failure with plasma creatinine levels equal to or greater than 2.5 mg/dl.
💡
Conclusion & Impact:We found that the mean value of BNP for 102 patients without a history of heart failure who had hemodialysis was 570.5±594.5 pg/ml and did not have hemodialysis was found 280.8±471.4 pg/ml (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives There is no known biomarker to indicate the necessity of hemodialysis in patients with acute renal failure. We aimed to determine if plasma brain natriuretic peptide levels are useful to indicate the necessity of hemodi- alysis in patients who are diagnosed with acute renal failure with plasma creatinine levels equal to or greater than 2.5 mg/dl. Methods This study was designed as a prospective study in a tertiary emergency department. Patients older than 14 years old who had plasma creatinine levels equal to or greater than 2.5 mg/dl and had not undergone hemo- dialysis regularly were consecutively enrolled in the study. A nephrologist decided the necessity of hemodialysis. Results 124 patients participated in the study. 46 were evaluated as having an indication for hemodialysis. We found that the mean value of BNP for pa- tients who required hemodialysis was 646.6±731.9 pg/ml and those that did not have hemodialysis was 446.2±723.9 pg/ml (p=0.141). We found that the mean values of BNP, 1040.1±1123.1 pg/ml for patients who had hemodialysis and 207.8±203.6 pg/ml for patients who did not have he- modialysis, in a total of 19 patients with acute renal failure on chronic re- nal failure (p=0.04). We found that the mean value of BNP for 102 patients without a history of heart failure who had hemodialysis was 570.5±594.5 pg/ml and did not have hemodialysis was found 280.8±471.4 pg/ml (p

Özet

AmaçAkut böbrek yetersizliği hastalarında hemodiyaliz ihtiyacını öngörenbir biyobelirteç bulunmamaktadır. Çalışmamızda serum kreatinin de- ğeri 2.5 mg/dl ve üzerinde olan akut böbrek yetersizliği hastalarında serum beyin natriüretik peptit (BNP) düzeylerinin hemodiyaliz ihtiyacı- nı öngörmedeki kullanılabilirliğini araştırdık.Gereç ve Yöntem Çalışmamız üçüncü basamak bir acil serviste ileri dönük olarak yapıldı. Serum kreatinin değeri 2.5 mg/dl ve üzerinde olan ve rutin diyaliz prog-ramında bulunmayan 14 yaşın üzerindeki hastalar çalışmaya ardışık olarak alındı. Olguların hemodiyaliz ihtiyacı olup olmadığına nefrolojiuzmanı tarafından karar verildi.BulgularÇalışmaya 124 hasta alındı, 46’sına (%37.1) hemodiyaliz endikasyo-nu konuldu. Hemodiyalize alınan hastaların BNP düzey ortalaması646.6±731.9 pg/ml, hemodiyalize alınmayan hastaların ise 446.2±723.9pg/ml saptandı (p=0.141). Kronik böbrek yetersizliği üzerine akut böb-rek yetersizliği gelişen 19 hastada, hemodiyalize alınan ve alınmayanhastaların BNP düzey ortalaması sırasıyla 1040.1±1123.1 pg/ml ve 207.8±203.6 pg/ml olarak bulundu (p=0.04). Öncesinde kalp yetersiz-liği öyküsü olmayan 102 hastada hemodiyalize alınanların BNP düzeyortalaması 570.5±594.5 pg/ml, hemodiyalize alınmayan hastaların ise280.8±471.4 pg/ml olarak bulundu (p

🔖

Cite This Article

TANRISEV, M., EYLER, Y., ÜSTÜNER, F., DOĞAN, T., KILIÇ, T. Y., DAĞAR, S., AKSAY, E. (2022). Can high bnp levels predict the necessity of emergency hemodialysis in patients with acute renal failure?. Türkiye Acil Tıp Dergisi, Cilt: 13 - Sayı: 3, 114–118. https://ajindex.com/articles/625944

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Doherty C. Epidemiology of acute renal failure. In: Davison AM, Cameron JS, Grünfeld JP, Ponticelli C, Ritz E, Winearls CG, et al. Oxford textbook of clinical nephrology. New York: Oxford University Press; 2005. p. 1435-43
  2. Lameire N, Biesen VW, Vanholder R. Epidemyology, clinical evaluation and prevention of acute renal failure. In: Feehally J, Floege J, Johnson RJ, et al. Comprehensive clinical nephrol- ogy. Philadelphia: Mosby; 2007. p. 979-1000
  3. Bektaş F, Nokay AE, Güngör F, Söyüncü S. Acil serviste akut böbrek yetmezliği tanısı alan hastaların özellikleri. Tr J Emerg Med 2008;8:170-4
  4. Sinert R, Peacock PR. Acute renal failure. In: Tintinalli JE, Stap- czynski JS, Ma OJ, Cline DM, Cydulka RK, Meckler GD, editors. Emergency medicine: a comprehensive study guide. New York: McGraw-Hill; 2010. p. 615-21
  5. Duygu H, Türk U, Zoghi M, Nalbantgil S. The importance of plasma B-type natriuretic peptide levels in cardiovascular dis- eases. Anadolu Kardiyol Derg 2005;5:305-11
  6. Porapakkham P, Porapakkham P, Zimmet H, Billah B, Krum H. B-type natriuretic peptide-guided heart failure therapy: A meta-analysis. Arch Intern Med 2010;170:507-14
  7. O’Donoghue M, Braunwald E. Natriuretic peptides in heart failure: should therapy be guided by BNP levels? Nat Rev Car- diol 2010;7:13-20
  8. Mark DB, Felker GM. B-type natriuretic peptide - a biomarker for all seasons? N Engl J Med 2004;350:718-20
  9. Palazzuoli A, Gallotta M, Quatrini I, Nuti R. Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure. Vasc Health Risk Manag 2010;6:411-8
  10. Maisel AS, Katz N, Hillege HL, Shaw A, Zanco P, Bellomo R, et al. Biomarkers in kidney and heart disease. Nephrol Dial Trans- plant 2011;26:62-74
  11. Franz M, Woloszczuk W, Hörl WH. N-terminal fragments of the proatrial natriuretic peptide in patients before and after he- modialysis treatment. Kidney Int 2000;58:374-83
  12. Aliustaoğlu M, Gümüş M, Gökçel A, Özer T, Bican M, Özdil K ve ark. Kronik böbrek yetmezliğinde hemodiyalizin atrial natriüretik peptid düzeylerine etkisi. J Kartal Tr 1999;2:740-2
  13. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jou- gasaki M, et al. Localization and mechanism of secretion of B- type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203
  14. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I, et al. Rapid transcriptional activation and ear